Janssen Research and Development (R&D), L.L.C., a member of Johnson & Johnson's Family of Companies, is seeking a Head of Investigative Immunotoxicology within the Biologics Toxicology organization located in Spring House, PA. This is a new group/role within the Biologics Toxicology organization and the Head will report directly to the Vice President and Head of Biologics Toxicology. The position is at the Senior Scientific Director level.
Janssen R&D, part of the Janssen Pharmaceutical companies of Johnson and Johnson (J&J), develops treatments that improve the health and lifestyles of people worldwide. R&D areas encompass novel targets in neurologic disorders, gastroenterology, oncology, infectious disease, diabetes, hematology, metabolic disorders, immunologic disorders, and reproductive medicine. For more about Janssen R&D, L.L.C., visit www.janssen.com/research-and-development. Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion, J&J is proud to be an equal opportunity employer.
The Head of Investigative Immunotoxicology for Biologics Toxicology will be a part of Janssen BioTherapeutics (JBIO; visit www.janssen.com/biotherapeutics ) and will support the development of novel biologic therapies which may include first-in-class technologies, stem cell therapies, monoclonal and multi-specific antibodies, alternative scaffolds, nucleic acid therapeutics, and protein molecules.
The Head of Investigative Immunotoxicology will establish a new group within Biologics Toxicology with the goal of evaluating potential immune system-related risks associated with our biotherapeutic pipeline. The candidate will expand on existing laboratory efforts in this area and, working with Project Toxicologists, will provide strategic and scientific input to multidisciplinary Project Teams progressing biotherapeutics from discovery to first-in-human and beyond. The Investigative Immunotoxicology group will use both internal and external (Contract Research Organizations) resources to generate data to support risk assessment. It is anticipated that the Investigative Immunotoxicology group will work to establish/develop novel assays/animal models to assist in understanding potential human risks associated with candidates in our biologics pipeline.
The Head of Investigative Immunotoxicology will be part of the Biologics Toxicology Senior Leadership Team. In addition, the candidate in this role will be part of the Biologics Toxicology Scientific Advisory Board. This Board is responsible for the review and approval of nonclinical safety strategies as well as major issue review and recommendations for resolution.
The candidate will manage both PhD level and technical level staff. They will also be responsible for the development of all employees within their group and within Biologics Toxicology by supporting the development of Human Resources Planning (HRP) programs including management development and training to meet current and future business needs and provide an environment, which encourages the company's commitment to equal employment opportunity and the value of a diverse work force. The candidate will also have responsibility for budget, resource and timeline commitments for the group.
The Head of Investigative Immunotoxicology for Biologics Toxicology will have a desire for learning and innovation, and continue career development through participation in scientific meetings, and increase visibility for self, Janssen BioTherapeutics and J&J through publications, participation in external organizations, and presentations at major scientific, industry, and regulatory meetings.